In Vitro Evaluation of the Anticancer and Immunomodulatory Activities of Stingless Bee Honey-Loaded Alginate Nanoparticles
Mohammad A. I. Al-Hatamleh, Walhan Alshaer, Ma’mon M. Hatmal, Ali Mussa, Ezaldeen Esawi, Suha Wehaibi, Mohd Zulkifli Mustafa, Rohimah MohamudObjectives
Stingless bee honey (SBH) has reported anticancer activity that is generally attributed to its phenolic acids and flavonoids. We previously described the synthesis, characterization, and wound-healing activity of SBH-loaded alginate nanoparticles (H-ALG NPs). Here, we evaluated the
Methods
Cytotoxicity of H-ALG NPs, crude SBH, and free alginate nanoparticles (free ALG NPs) was assessed by MTT assay in four cancer cell lines (MCF-7, MDA-MB-231, A549, U87) and in normal human dermal fibroblasts (HDFa). Cell migration was evaluated by
Results
H-ALG NPs showed significantly greater cytotoxicity than crude SBH against the four cancer cell lines (P < 0.01), with IC
50
values of 30.70 ± 3.44 µg/mL (MCF-7), 71.23 ± 5.17 µg/mL (U87), 73.59 ± 7.31 µg/mL (A549), and 84.45 ± 8.81 µg/mL (MDA-MB-231). Viability of HDFa fibroblasts was not reduced below 50% up to 1000 µg/mL. In the scratch assay, H-ALG NPs reduced wound closure more than crude SBH or free ALG NPs. By qPCR, H-ALG NPs increased
Conclusion
H-ALG NPs showed selective